Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon

American Heart Journal

Volumn 146, Issue 1, 2003, Pages 84-90

  Beltrame, John F ^a,b   Limaye, Sananand B ^a   Wuttke, Ronald D ^a   Horowitz, John D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Queen Elizabeth Hospital Campus   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; FEMALE; HEART ATRIUM PACING; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; MALE; PRIORITY JOURNAL; STIMULUS RESPONSE; VASODILATATION;

EID: 0038499329     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00124-8     Document Type: Article

References (28)

1. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology 2002;97:197-202.
2. Mosseri M, Yarom R, Gotsman MS, et al. Histologic evidence for small-vessel coronary artery disease in patients with angina and patent large coronary arteries. Circulation 1986;74:964-72.
3. Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996;37:375-81.
4. Chesebro J, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-54.
5. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88.
6. Ganz W, Tamura K, Marcus H, et al. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971;44:181-95.
7. Buttery J, Chamberlain B, Milner C, et al. Calorimetric assay of plasma lactates. Am J Clin Pathol 1985;84:363-6.
8. OSM2 Hemoximeter: specific performance characteristics. In: OSM2 Hemoximeter User's Handbook. Copenhagen: Radiometer; 1990. p. 73-9.
9. Cowan C, McKenzie J. Cholinergic regulation of resting coronary blood flow in domestic swine. Am J Physiol 1990;259:109-15.
10. Mudge G, Grossman W, Mills R, et al. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med 1976;295:1333-7.
11. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
12. Newman C, Maseri A, Hackett D, et al. Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. Am J Cardiol 1990;66:1070-6.
13. Crake T, Canepa-Anson R, Shapiro L, et al. Continuous recording of coronary sinus O2 saturation during atrial pacing in patients with coronary artery disease or syndrome X. Br Heart J 1988;59:31-8.
14. Miwa K, Fujita M, Ejiri M, et al. Biphasic changes (initial increase and late decrease) in coronary sinus venous oxygen saturation during anginal attacks induced by intracoronary acetylcholine in patients with variant angina. Cardiology 1992;81:221-32.
15. Rosano G, Kaski J, Arie S, et al. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries: evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J 1996;17:1175-80.
16. Crossman DC, Larkin SW, Fuller RW, et al. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 1989;80:475-84.
17. Bagger J. Coronary sinus blood flow determination by the thermodilution technique: influence of catheter position and respiration. Cardiovasc Res 1984;19:27-31.
18. Ge J, Simon H, Jeremias A, et al. Angiographic coronary slow flow phenomenon indicates microvascular dysfunction: an intra-coronary doppler study. Circulation 1997;8:1-273.
19. Van Lierde J, Vrolix M, Sionis D, et al. Lack of evidence for small vessel disease in a patient with "slow dye progression" in the coronary arteries. Cathet Cardiovasc Diagn 1991;23:117-20.
20. Murakami H, Urabe K, Nishimura M. Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X. J Am Coll Cardiol 1998;32:1287-94.
21. Beltrame JF, Horowitz JD. ST elevation secondary to microvascular dysfunction. J Am Coll Cardiol 1999;34:312-3.
22. Murakami H, Urabe K, Nishimura M. ST elevation secondary to microvascular dysfunction. J Am Coll Cardiol 1999;34:313-4.
23. Rosano G, Crea F. Chest pain and myocardial ischemia in syndrome X: new pathogenetic hypotheses. Coron Artery Dis 1992;3:599-604.
24. Kaski J, Tousoulis D, Rosano G, et al. Role of neuropeptide Y in the pathogenesis of syndrome X. Eur Heart J 1992;13:103.
25. Kurihara H, Yamaoki K, Nagai R, et al. Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci 1989;44:1937-43.
26. Larkin SW, Clarke JG, Keogh BE, et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 1989;64:956-8.
27. Hirata K, Matsuda Y, Akita H, et al. Myocardial ischaemia induced by endothelin in the intact rabbit: angiographic analysis. Cardiovasc Res 1990;24:879-83.
28. Di Donato M, Fantini F, Maioli M, et al. Blood velocity in the coronary artery circulation: relation to thromboxane A2 levels in coronary sinus in patients with angiographically normal coronary arteries. Cathet Cardiovasc Diagn 1987;13:162-6.